Introduction
The Basic and Clinical Intestinal Disorders (BCID) section represents a community of clinical, translational and basic scientists interested in disease-focused and pathwaydriven processes underlying:
Celiac disease and food intolerances; Radiation, chemotherapy, and hypoxia-induced injury and repair; Diarrhea, malabsorption and enteropathies.
Microbial pathogenesis and mechanisms of microbehost cross talk; Nutrient, solute, salt and water transport;
Epithelial cell and molecular biology;
Epithelial barrier function and wound repair; Epithelial functions in innate immunity and inflammation; and Irritable bowel syndrome.
Our section aims to foster collaboration among interactive scientific communities by featuring outstanding basic, translational and clinical research in these areas.
Research Mentor Award
Established in 2010, the Research Mentor Award recognizes AGA members for their achievements as outstanding mentors in a specific area of research. Members are awarded from each of the 13 AGA council sections.
For Basic and Clinical Intestinal Disorders (BCID) the award will be presented to Wayne I. Lencer, MD, AGAF during the session, Pathogenesis of Mucosal Disease: Ying and Yang of Inflammation, Saturday, May 18 at 10 a.m. in room 29CD.
Introduction
The AGA Council section Cellular & Molecular Gastroenterology (CMG) has broad interests in the basic mechanisms underlying digestive diseases and gastrointestinal biology. The section's membership has interests representing many areas of cutting-edge science, including growth factors, stem cells, cellular differentiation, epigenetics, mechanisms of receptor function, basic physiology and cell biology, luminal chemosensing, intestinal inflammation, and mucosal injury and healing. CMG strives to invite outside speakers who are leading scientists in their fields to present forward-looking scientific programming at DDW.
We have an exciting lineup for DDW 2019. CMG will sponsor a distinguished abstract plenary session, 4 research symposia, 6 research fora, and 8 poster sessions. We look forward to seeing you at DDW! In this plenary, top abstracts from the CMG Section, with an emphasis, on stem cells and plasticity, will be presented. Attendees will learn about how stem cells are recruited in injury and how that might underlie metaplasia.
Research Fora
Metaplasia seems to involve recruitment of stem cells as part of the normal repair process. Here, luminaries in the field explain how injury causes metaplasia.
Monday, May 20, 2019: "Defining Gastrointestinal Inflammation at the Organellar Level"
Recently it has become clear that a cell's metabolic programming can change in inflammation. Here, top investigators explain how autophagy and mitochondrial dynamics can determine the outcome of inflammation.
Tuesday, May 21, 2019: "Transcriptional Regulation of Gastrointestinal Cell Identity"
Here, top investigators will detail how cells use transcriptional and epitranscriptional regulation to differentiate and respond to injury and inflammation in the GI tract.
Research Mentor Award
For CMG the award will be presented to Mark Donowitz, MD, AGAF during the session, Cellular & Molecular Gastroenterology (CMG) Section Distinguished Abstract Plenary:
Introduction
The mission of the Clinical Practice (CP) section is to promote the optimum delivery of high quality, cost-effective gastrointestinal healthcare. Best practices will primarily be identified through cutting-edge research in areas such as epidemiology, population health screening, outcomes research, performance metrics, health economics, systematic reviews, practice management and medical education.
Research Fora
The CP section will feature four research fora, which will have oral abstract presentations and invited speakers centered on general themes. These include the following: 
Distinguished Abstract Plenary
The Clinical Practice section will hold its distinguished abstract plenary on Monday, May 20 at 8 a.m. in room 9.
Symposia
The CP section will feature seven symposia, including clinical topics and highlighting recent practice guidelines. These include the following: 
Research Mentor Award
For Clinical Practice, the award will be presented to Linda Rabeneck, MD, MPH during Clinical Practice (CP) Section Distinguished Abstract Plenary, Monday, May 20, at 8 a.m., in room 9.
Introduction
The AGA Institute Council Esophageal, Gastric and Duodenal Disorders (EGD) Section continues to heavily contribute to the educational and research mission of the AGA Institute and remains a highly visible section at Digestive Disease Week® (DDW). The section is diverse in regards to representation of multiple upper GI diseases including esophagus, stomach and duodenum. Advances continue to develop in the area of esophageal reflux and motility testing (e.g., high resolution manometry and mucosal impedance measurements), endoscopic reflux therapies, as well as continued strong interest in both clinical and basic research in eosinophilic esophagitis and Barrett's esophagus. Dominant areas of investigation in this section include esophageal physiologic testing, eosinophilic esophagitis, H. pylori infection and its chronic implications, GERD and extraesophageal GERD, Barrett's esophagus, esophageal and gastric dysmotility, and GI bleeding.
Research Fora
The EGD section will feature 10 research fora, which will have a mix of invited speaker presentations and oral abstract presentations on general themes. These include the following:
Saturday 
Distinguished Abstract Plenary
The EGD section will hold its distinguished abstract plenary on Tuesday, May 21 at 8 a.m. in room 9. 
Poster Sessions

Research Mentor Award
For Esophageal, Gastric & Duodenal Disorders, the award will be presented to Stuart Jon Spechler, MD, AGAF,
Introduction
The Gastrointestinal Oncology (GIONC) Section is dedicated to expanding and advancing the science and practice of gastroenterology primarily by providing educational leadership in topics central to the initiation, progression, diagnosis and treatment of gastrointestinal tract cancers. Our program includes the latest advances in clinical, translational, and basic science research. We focus in two broad, inter-related themes of organ systems and gastrointestinal cancer biology.
Research Fora
The Gastrointestinal Oncology research fora intend to showcase high quality abstracts submitted to the section for presentation in San Diego this year. Fora topics were chosen to bring together thematically related abstracts that both reflect section members' interests, and to foster interaction between presenters and attendees. These sessions will focus on clinical advances in two "hot areas" of GI cancer: hereditary GI cancer genetics and chemoprevention. Both sessions will provide "state-ofthe-art" updates, including the release of the first public results of data from two large, randomized controlled trials.
Monday, May 20, 2019: "Inflammation, Immune Suppression, and Tumor Immunology" This session will explore the balance between inflammation and immunity, which play pivotal roles in the initiation, progression, and, most recently, the treatment of GI cancers.
Tuesday, May 21, 2019: "The Microbiome and GI Cancer"
This session will provide "state-of-the-art" updates on the role of the gut microbiome in promoting the onset and progression of a number of GI cancers.
Research Mentor Award
For Gastrointestinal Oncology, the award will be presented to Richard M. Peek, Jr. MD, AGAF during the GIONC Distinguished Abstract Plenary on Monday, May 20, at 4 p.m., in room 29B.
Introduction
The AGA Institute Council Imaging, Endoscopy and Advanced Technology (IEAT) Section identifies research submitted to Digestive Disease Week® (DDW) that incorporates novel applications or improvements to existing technology or new techniques that image or treat disorders of the gastrointestinal tract, liver, bile ducts, gallbladder or pancreas. Along with other sections of the council, it designs multidisciplinary symposia and sessions for DDW that are designed to appeal to clinicians and scientists in gastroenterology, surgery and radiology. Future goals of the section include identification and highlighting of cutting-edge technology in endoscopy, radiology, imaging and molecular techniques.
Research Fora
The IEAT section will feature three research fora. These include the following: 
Introduction
The AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section executes AGA's strategic plan by providing an international forum to present and evaluate the most exciting and innovative research in the field. By providing a forum for debate, collaboration and an exchange of ideas, the IMIBD section helps define what is state-of-the-art care in IBD and pushes the boundaries of science in search of a cure. Established and emerging leaders collate this information to provide education and training to both the next generation of researchers as well as for providers caring for patients with IBD. This enhanced knowledge leads to improved practice and quality, ultimately showing the value of section through the work of its diverse members.
Research Fora
The IMIBD section will feature 13 research fora, which will have a mix of invited speaker presentations and oral abstract presentations on general themes. These include the following:
Saturday, May 18, 2019: "Epidemiology and Natural History of IBD", "Improving Quality of Care and Quality of Life in the Patient With IBD", "Sunrise, Sunset: Pediatric and 
Introduction
The Liver & Biliary (LB) section is dedicated to advancing the science and clinical practice of gastroenterology by providing leadership in topics central to the epidemiology, diagnosis and treatment of acute and chronic hepatobiliary diseases. The section is focused on providing state-of-the-art programming in all aspects of clinical, translational and basic science research as it relates to liver disease and transplantation. It is the second largest section in the AGA Council, and collaborates with multiple AGA sections and the American Association for the Study of Liver Diseases (AASLD) in offering abstract-driven sessions at Digestive Disease Week® (DDW).
The LB section will feature 3 fora, the majority of which will showcase both abstract and invited presentations. They encompass areas of major scientific advance in liver and biliary disease.
Saturday, May 18, 2019: "Biliary Tract Disease" Both gastroenterologists and specialized hepatologists require expertise in biliary tract disease to be effective clinicians. This session will provide new information in this critical transitional area Sunday, May 19, 2019: "NASH" NASH has surpassed hepatitis C as the main reason for liver transplantation in the U.S. and elsewhere. In light of a burgeoning obesity epidemic, NAFLD and NASH will continue to increase. New diagnostic methods and treatments will be highlighted.
Monday, May 20, 2019: "Advanced Liver Disease" Complications of chronic liver disease require carefully skilled hepatology skills to manage. This session will provide state of the art knowledge in the area. 
Poster Sessions
Research Fora
The MMT is offering research sessions that feature outstanding speakers who will present findings that highlight emerging areas of discovery that advance our understanding of the role of the gut microbiome in health and disease. MMT is also happy to co-sponsor many sessions this year as the microbiome is a cross cutting field of interest that goes beyond this section. Please be sure to use the mobile planner and app once its available to see all the MMT related sessions. For MMT, the award will be presented to R. Balfour Sartor, MD during the session, A Host Perspective of the Inflamed Gut Microbiome, on Monday, May 20 at 2 p.m. in room 29CD.
Introduction
The Neurogastroenterology & Motility (NGM) section of the AGA Council is dedicated to serving the field of neurogastroenterology and gastrointestinal motility by promoting excellence in research, innovation, education and training Some of the sections main goals are:
To attract the best science and cutting-edge research in neurogastroenterology and GI motility for presentation at Digestive Disease Week® (DDW). To educate and train gastroenterologists, research scientists, surgeons, physiologists, trainees, nurses and technicians on the latest developments in the field.
To foster interdisciplinary basic science, translational and clinical research. To lead and critically examine the development of novel tools for studying neurogastroenterology and motility disorders, and gut and brain interactions, both at the bench side and for patient care.
In recent years, DDW programming by the Obesity, Metabolism and Nutrition (OMN) section has emphasized subject areas that have appealed to a majority of meeting attendees, especially those affiliated not only with the OMN section, but also other sections with which we share common interests, as reflected by our strong participation in cross-sectional programming. Our programming includes fora and symposia highlighting related topics, including bariatric surgery, GI neuroendocrinology and metabolism, new and innovative endoscopic and other treatments of obesity and diabetes, fatty liver disease, GI regulation of energy balance, weight and metabolic function, microbiota and metabolic regulation, and nutrition and metabolism across the life cycle. Nutritional support in all of its forms used in the management of a variety of diseases, including obesity, intestinal failure and inflammatory bowel disease, as well as nutrient absorption and metabolism, have also continued to be the focus of OMN programming. The OMN section has also endeavored to strike a balance between basic research to shed light on disease mechanisms, including pre-clinical studies to develop new therapies, and clinical and translational research to better describe disease phenotypes and test new therapeutic approaches. 
Research Fora
Research Mentor Award
For OMN, the award will be presented to Kelly A. Tappenden, PhD, RD during the session, Nutrigenomics and Personalized Nutrition in Gastroenterology: Ready for Prime Time?, on Sunday, May 19 at 2 p.m. in room 24ABC.
